Steven Martin is a biochemist who studies the signalling mechanisms associated with cell growth, division and migration. In particular, he looks at how signalling pathways influence the malignant transformation of cells, during the development of cancer.

Using both genetic and biochemical approaches, Steven studies oncogenes that when mutated have the potential to cause cancer. He and his team have identified regulatory enzymes that signal the autonomous growth of cancer cells and their invasion into areas of normal tissue. He also investigates how cancer cells respond to drugs that target the proteins encoded by mutated oncogenes.

By understanding the growth and migration of cancer cells at a molecular level, Steven aims to find ways to diagnose and manage the disease. His research is enabling the development of tests that will improve the diagnosis and treatment of cancer by revealing the signalling pathways upon which the cancer cells depend.